PubMed

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma.

Prentice LM, Klausen C, Kalloger S, Köbel M, McKinney S, Santos JL, Kenney C, Mehl E, Gilks CB, Leung P, Swenerton K, Huntsman DG, Aparicio SA.

BMC Med. 2007 Nov 15;5:33.PMID: 18005407 [PubMed - indexed for MEDLINE]Related articlesFree article

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D.

PLoS Med. 2008 Dec 2;5(12):e232.PMID: 19053170 [PubMed - indexed for MEDLINE]Related articlesFree article

Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss.

Clarke B, Tinker AV, Lee CH, Subramanian S, van de Rijn M, Turbin D, Kalloger S, Han G, Ceballos K, Cadungog MG, Huntsman DG, Coukos G, Gilks CB.

Mod Pathol. 2009 Mar;22(3):393-402. Epub 2008 Dec 5.PMID: 19060844 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.

Nakayama K, Kanzaki A, Terada K, Mutoh M, Ogawa K, Sugiyama T, Takenoshita S, Itoh K, Yaegashi N, Miyazaki K, Neamati N, Takebayashi Y.

Clin Cancer Res. 2004 Apr 15;10(8):2804-11.PMID: 15102688 [PubMed - indexed for MEDLINE]Related articlesFree article

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype.

Köbel M, Xu H, Bourne PA, Spaulding BO, Shih IeM, Mao TL, Soslow RA, Ewanowich CA, Kalloger SE, Mehl E, Lee CH, Huntsman D, Gilks CB.

Mod Pathol. 2009 Mar;22(3):469-75. Epub 2009 Jan 9.PMID: 19136932 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of metastin expression in human pancreatic cancer.

Nagai K, Doi R, Katagiri F, Ito T, Kida A, Koizumi M, Masui T, Kawaguchi Y, Tomita K, Oishi S, Fujii N, Uemoto S.

J Exp Clin Cancer Res. 2009 Jan 21;28:9.PMID: 19154616 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of a functional g protein-coupled receptor 54-kisspeptin autoregulatory system in hypothalamic gonadotropin-releasing hormone neurons.

Quaynor S, Hu L, Leung PK, Feng H, Mores N, Krsmanovic LZ, Catt KJ.

Mol Endocrinol. 2007 Dec;21(12):3062-70. Epub 2007 Aug 14.PMID: 17698953 [PubMed - indexed for MEDLINE]Related articlesFree article

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G, Zeimet AG.

Gynecol Oncol. 2006 Nov;103(2):483-8. Epub 2006 May 6.PMID: 16678891 [PubMed - indexed for MEDLINE]Related articles

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, Nørgaard-Pedersen B, Høgdall CK.

Cancer. 2003 Jul 1;98(1):66-73.PMID: 12833457 [PubMed - indexed for MEDLINE]Related articlesFree article

Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Di Carlo L, Semeraro A, Daddi G, Darwish S, Stocchi L, Tofanetti FR, Bellezza G, Sidoni A, Tognellini R, Crinò L, Tonato M.

Tumori. 2008 May-Jun;94(3):398-405.PMID: 18705409 [PubMed - indexed for MEDLINE]Related articles

LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.

Yang Y, Yang H, McNutt MA, Xiong F, Nie X, Li L, Zhou R.

Oncol Rep. 2008 Nov;20(5):1077-83.PMID: 18949404 [PubMed - indexed for MEDLINE]Related articles

The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.

Nakopoulou L, Lazaris AC, Panayotopoulou EG, Giannopoulou I, Givalos N, Markaki S, Keramopoulos A.

J Clin Pathol. 2004 May;57(5):523-8.PMID: 15113861 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas.

Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, Lopes CS.

Ann Oncol. 2004 Oct;15(10):1535-42.PMID: 15367415 [PubMed - indexed for MEDLINE]Related articlesFree article

Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type.

Yamamoto S, Tsuda H, Honda K, Kita T, Takano M, Tamai S, Inazawa J, Yamada T, Matsubara O.

Mod Pathol. 2007 Dec;20(12):1278-85. Epub 2007 Sep 14.PMID: 17873890 [PubMed - indexed for MEDLINE]Related articlesFree article

Intracellular signaling pathways activated by kisspeptins through GPR54: do multiple signals underlie function diversity?

Castaño JP, Martínez-Fuentes AJ, Gutiérrez-Pascual E, Vaudry H, Tena-Sempere M, Malagón MM.

Peptides. 2009 Jan;30(1):10-5. Epub 2008 Aug 15. Review.PMID: 18775460 [PubMed - indexed for MEDLINE]Related articles

Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.

Brustmann H.

Gynecol Oncol. 2005 Sep;98(3):396-402.PMID: 16005054 [PubMed - indexed for MEDLINE]Related articles

MDM2 protein expression is a negative prognostic marker in breast carcinoma.

Turbin DA, Cheang MC, Bajdik CD, Gelmon KA, Yorida E, De Luca A, Nielsen TO, Huntsman DG, Gilks CB.

Mod Pathol. 2006 Jan;19(1):69-74.PMID: 16258514 [PubMed - indexed for MEDLINE]Related articlesFree article

Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients.

Moilanen J, Lassus H, Leminen A, Vaheri A, Bützow R, Carpén O.

Gynecol Oncol. 2003 Aug;90(2):273-81.PMID: 12893187 [PubMed - indexed for MEDLINE]Related articles

The kisspeptin receptor GPR54 is required for sexual differentiation of the brain and behavior.

Kauffman AS, Park JH, McPhie-Lalmansingh AA, Gottsch ML, Bodo C, Hohmann JG, Pavlova MN, Rohde AD, Clifton DK, Steiner RA, Rissman EF.

J Neurosci. 2007 Aug 15;27(33):8826-35.PMID: 17699664 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.

Hoffman BR, Katsaros D, Scorilas A, Diamandis P, Fracchioli S, Rigault de la Longrais IA, Colgan T, Puopolo M, Giardina G, Massobrio M, Diamandis EP.

Br J Cancer. 2002 Sep 23;87(7):763-71.PMID: 12232761 [PubMed - indexed for MEDLINE]Related articlesFree article